Eugene D. Kwon

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

Eugene D. Kwon, Charles G. Drake, H. I. Scher et al. · The Lancet Oncology · 2014 · 1.5K citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up

R. Houston Thompson, Susan M. Kuntz, Bradley C. Leibovich et al. · Cancer Research · 2006 · 870 citations · Full text

Medicine, Immunology, Oncology +13

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma

Bradley C. Leibovich, Michael L. Blute, John C. Cheville et al. · Cancer · 2003 · 831 citations

Medicine, Oncology, Surgery +17

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

R. Houston Thompson, Michael D. Gillett, John C. Cheville et al. · Proceedings of the National Academy of Sciences · 2004 · 766 citations · Full text

Medicine, Immunology, Oncology +17

Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer

Tomasz M. Beer, Eugene D. Kwon, Charles G. Drake et al. · Journal of Clinical Oncology · 2016 · 754 citations · Full text

Medicine, Oncology, Pharmacology +17